⚕️ The information below is for educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Consult your healthcare provider before starting any medication.
More than 32 million Indians live outside India, making the Indian diaspora one of the largest in the world. Whether you are a software engineer in the US, a nurse in the UK, a businessman in Dubai, or a student in Australia, if you are South Asian and struggling with weight or type 2 diabetes, GLP-1 medications are increasingly relevant to you.
But navigating GLP-1 therapy as an NRI (Non-Resident Indian) comes with a specific set of challenges that no standard guide addresses: different brand names, vastly different prices, prescription rules that vary by country, cold chain issues when visiting India, and the practical reality of managing therapy between two healthcare systems. This guide addresses all of that.
This is the most confusing part for NRIs. The same molecule has different brand names in different countries, and some formulations approved in one country are not available in another.
| Brand Name | Country | Indication | Dose Range |
|---|---|---|---|
| Ozempic | India, US, UK, UAE, Canada, Australia, EU | Type 2 diabetes (weekly injection) | 0.25 mg → 2 mg |
| Wegovy | US, UK, EU, Canada, Australia | Weight loss (weekly injection) | 0.25 mg → 2.4 mg |
| Rybelsus | India, US, UK, EU, UAE | Type 2 diabetes (daily oral tablet) | 3 mg → 14 mg |
Key NRI note: Wegovy (the higher-dose weight-loss formulation of semaglutide) is not approved in India as of 2026. If you are on Wegovy in the US or UK and return to India for a holiday or extended visit, you cannot get Wegovy here — only Ozempic (lower dose) or Rybelsus. Discuss with your doctor abroad how to manage this gap.
| Brand Name | Country | Indication |
|---|---|---|
| Mounjaro | India, US, UK, UAE, EU, Canada, Australia | Type 2 diabetes (weekly injection) |
| Zepbound | US, UK | Weight loss (weekly injection) |
Key NRI note: Zepbound (tirzepatide for weight management) is not approved in India as of 2026. Mounjaro is available in India but primarily marketed for diabetes. Your Indian doctor may prescribe it off-label for weight management.
GLP-1 medications are dramatically cheaper in India than in the US or UK — this is one of the most important facts for NRIs to know.
| Country | Monthly Cost (Approximate) | Notes |
|---|---|---|
| India | ₹6,000–12,000 (~$70–140 USD) | No insurance subsidy needed |
| United States (no insurance) | $800–1,200 USD (~₹67,000–100,000) | With GoodRx: ~$400–600 |
| United States (with insurance) | $25–50 USD copay | Depends on plan; prior auth often required |
| United Kingdom (NHS) | Free (if prescribed for diabetes) | NHS does not routinely prescribe for weight loss only |
| United Arab Emirates | AED 600–900 (~$160–245 USD) | More affordable than US; no subsidy |
| Canada | CAD 200–400 (~$150–300 USD) | Partial coverage varies by province |
| Australia | AUD 100–200 (~$65–130 USD) | PBS subsidy for diabetes indication |
The bottom line: India is one of the cheapest countries in the world to purchase Ozempic or Mounjaro. Many NRIs from the US who visit India stock up on several months' supply — legally, as a personal-use quantity.
This is a common and important question. The short answer is: yes, for personal use in most cases, but rules vary by country.
Important for all countries: Always carry your prescription and doctor's letter. Keep medications in the original manufacturer's packaging. Do not carry unmarked syringes or pens without documentation.
GLP-1 medications require refrigeration (2–8°C) when stored long-term. During international travel, managing the cold chain is critical.
If you are on GLP-1 therapy abroad and need a prescription or supply during an India visit:
If your US or UK doctor is unfamiliar with Indian brand names, tell them:
If you move back to India temporarily (more than 3 months):
GLP-1 medications are particularly relevant to South Asians (Indians, Pakistanis, Bangladeshis, Sri Lankans), who have:
In the US, UK, and Canada, South Asian patients are increasingly being recognised as candidates for GLP-1 therapy at lower BMI thresholds than the standard criteria — discuss this specifically with your doctor if you feel your BMI does not "qualify" you by standard Western criteria.
NICE (UK) guidance and ADA/EASD guidelines both acknowledge ethnicity-adjusted thresholds for South Asians.
Q: I am on Wegovy 2.4 mg in the US. If I come to India for 2 months, what do I do? Bring a 2-month supply from the US (within personal import limits — typically 90 days). Keep it in a Frio wallet during travel. If you cannot bring enough supply, the highest available semaglutide dose in India via Ozempic is 1 mg/week; discuss with your US doctor whether stepping down temporarily is appropriate.
Q: Can my Indian doctor's prescription work at a US pharmacy? Generally no — US pharmacies require prescriptions from US-licensed physicians. However, an Indian prescription is useful documentation when crossing US customs with your medication.
Q: Is the Ozempic available in India the same as in the US? Yes. Both are manufactured by Novo Nordisk to the same global standard. The semaglutide molecule and formulation are identical; only the labelling and packaging language differ.
Q: My company insurance in the US covers GLP-1. Can I use my insurance to buy from an Indian pharmacy? No — US insurance only covers purchases from US pharmacies. However, paying out-of-pocket in India is so much cheaper that many NRIs still choose to buy here.
Q: I have dual citizenship / an OCI card. Does it affect my ability to get a prescription in India? No. OCI card holders can access Indian healthcare as residents. Any registered doctor in India can issue you a prescription.
Consult your healthcare provider before starting any medication. GLP-1 therapy across international healthcare systems requires coordination between your home-country and Indian doctors; a brief consultation with an Indian endocrinologist before and after any extended India visit is strongly recommended.
